“…2,3 However, PDT still faces many problems in therapeutic application, 4 such as (1) the limited penetration depth of light; (2) the hypoxic microenvironment of the tumor leading to an insufficient O 2 supply during treatment, which limits the therapeutic efficiency of PDT; 5–7 and (3) the high level of reducing substances in cancer cells, such as glutathione (GSH), which can consume ROS produced by PDT. 8–10 Therefore, alleviating the tumor hypoxic microenvironment and reducing the level of reducing substances in tumor cells are the key to improving the effect of PDT. 11…”